Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Nomacopan achieves primary endpoint at interim analysis of phase III CAPSTONE study

Jan. 13, 2020

Apellis announces positive topline data from phase III PEGASUS study of pegcetacoplan in PNH

Jan. 8, 2020

New humanized transgenic mouse model of FNAIT

Jan. 8, 2020

Mim8, an FVIII mimetic antibody, shows promise for hemophilia A

Jan. 7, 2020

Phase II data presented for sevuparin in SCD patients with acute painful vaso-occlusive crisis

Jan. 7, 2020

U.S. researchers present novel coagulation factor VIIa chimera for hemophilia patients

Jan. 2, 2020

Regeneron begins open-label extension study with REGN-3918 in PNH

Jan. 2, 2020

PGC-1alpha as a novel therapeutic target in sickle cell disease

Jan. 2, 2020

Phase I data presented for ambrisentan in sickle cell disease

Jan. 2, 2020

Phase II data presented for efgartigimod in adults with primary ITP

Dec. 31, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...